5.95
+5.95(+1.19%)
Currency In USD
| Previous Close | 5.95 |
| Open | 6.06 |
| Day High | 6.06 |
| Day Low | 5.45 |
| 52-Week High | 45.9 |
| 52-Week Low | 3.88 |
| Volume | 17,155 |
| Average Volume | 107,042 |
| Market Cap | 4.32M |
| PE | -0.04 |
| EPS | -141.32 |
| Moving Average 50 Days | 8.42 |
| Moving Average 200 Days | 13.27 |
| Change | 5.95 |
If you invested $1000 in Predictive Oncology Inc. (POAI) 10 years ago, it would be worth $0.02 as of December 25, 2025 at a share price of $5.95. Whereas If you bought $1000 worth of Predictive Oncology Inc. (POAI) shares 5 years ago, it would be worth $28.5 as of December 25, 2025 at a share price of $5.95.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Data not available
Predictive Oncology Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement
GlobeNewswire Inc.
Dec 02, 2025 1:00 PM GMT
PITTSBURGH, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a AI-driven drug discovery company that has expanded its business to include a digital asset strategy focused on ATH, the native utility token of the Aethir netw
Predictive Oncology Announces Additions to Board and Leadership Team to Support Digital Asset Treasury Strategy
GlobeNewswire Inc.
Oct 14, 2025 12:00 PM GMT
Appoints Shawn Matthews, CEO of DNA Holdings Venture, Inc., and Former CEO of Cantor Fitzgerald, to its Board of Directors Names Thomas McLaughlin and Sara Turken, JD, as Chief Investment Officer and General Counsel, respectively PITTSBURGH, Oct. 14
Predictive Oncology Inc. Announces Closing of $343.5 Million in Private Placements to Initiate Digital Asset Treasury Strategy
GlobeNewswire Inc.
Oct 08, 2025 1:00 PM GMT
Investment creates the world’s first Strategic Compute Reserve Strategy complements Predictive Oncology’s AI/ML-driven drug discovery and development activities PITTSBURGH, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (“Predictive On